These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
425 related items for PubMed ID: 8622883
1. The role of p16 in the E2F-dependent thymidine kinase regulation. Hengstschläger M, Hengstschläger-Ottnad E, Pusch O, Wawra E. Oncogene; 1996 Apr 18; 12(8):1635-43. PubMed ID: 8622883 [Abstract] [Full Text] [Related]
2. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins. Alevizopoulos K, Vlach J, Hennecke S, Amati B. EMBO J; 1997 Sep 01; 16(17):5322-33. PubMed ID: 9311992 [Abstract] [Full Text] [Related]
4. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity. Johnson DG. Oncogene; 1995 Nov 02; 11(9):1685-92. PubMed ID: 7478595 [Abstract] [Full Text] [Related]
5. Expression of p16 induces transcriptional downregulation of the RB gene. Fang X, Jin X, Xu HJ, Liu L, Peng HQ, Hogg D, Roth JA, Yu Y, Xu F, Bast RC, Mills GB. Oncogene; 1998 Jan 08; 16(1):1-8. PubMed ID: 9467937 [Abstract] [Full Text] [Related]
6. Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter. Spitkovsky D, Schulze A, Boye B, Jansen-Dürr P. Cell Growth Differ; 1997 Jun 08; 8(6):699-710. PubMed ID: 9186003 [Abstract] [Full Text] [Related]
7. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions. Oswald F, Lovec H, Möröy T, Lipp M. Oncogene; 1994 Jul 08; 9(7):2029-36. PubMed ID: 8208548 [Abstract] [Full Text] [Related]
8. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes. Haddad MM, Xu W, Schwahn DJ, Liao F, Medrano EE. Exp Cell Res; 1999 Dec 15; 253(2):561-72. PubMed ID: 10585280 [Abstract] [Full Text] [Related]
9. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators. Morris L, Allen KE, La Thangue NB. Nat Cell Biol; 2000 Apr 15; 2(4):232-9. PubMed ID: 10783242 [Abstract] [Full Text] [Related]
10. Control of E2F activity by p21Waf1/Cip1. Delavaine L, La Thangue NB. Oncogene; 1999 Sep 23; 18(39):5381-92. PubMed ID: 10498892 [Abstract] [Full Text] [Related]
11. Overexpression of p21waf1 leads to increased inhibition of E2F-1 phosphorylation and sensitivity to anticancer drugs in retinoblastoma-negative human sarcoma cells. Li WW, Fan J, Hochhauser D, Bertino JR. Cancer Res; 1997 Jun 01; 57(11):2193-9. PubMed ID: 9187120 [Abstract] [Full Text] [Related]
12. c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases. Alexandrow MG, Moses HL. J Cell Biochem; 1998 Sep 15; 70(4):528-42. PubMed ID: 9712150 [Abstract] [Full Text] [Related]
13. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F. Hiyama H, Iavarone A, Reeves SA. Oncogene; 1998 Mar 26; 16(12):1513-23. PubMed ID: 9569018 [Abstract] [Full Text] [Related]
14. Conserved region 2 of adenovirus E1A has a function distinct from pRb binding required to prevent cell cycle arrest by p16INK4a or p27Kip1. Alevizopoulos K, Sanchez B, Amati B. Oncogene; 2000 Apr 13; 19(16):2067-74. PubMed ID: 10803468 [Abstract] [Full Text] [Related]
15. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes. Furukawa Y, Iwase S, Kikuchi J, Nakamura M, Yamada H, Matsuda M. Oncogene; 1999 Mar 18; 18(11):2003-14. PubMed ID: 10208422 [Abstract] [Full Text] [Related]
16. The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering. Alesse E, Zazzeroni F, Angelucci A, Giannini G, Di Marcotullio L, Gulino A. Cell Death Differ; 1998 May 18; 5(5):381-9. PubMed ID: 10200487 [Abstract] [Full Text] [Related]
17. Functional interplay between p53 and E2F through co-activator p300. Lee CW, Sørensen TS, Shikama N, La Thangue NB. Oncogene; 1998 May 28; 16(21):2695-710. PubMed ID: 9652736 [Abstract] [Full Text] [Related]
18. Rb dephosphorylation and suppression of E2F activity in human breast tumor cells exposed to a pharmacological concentration of estradiol. Gewirtz DA, Di YM, Randolph JK, Jain PT, Valerie K, Bullock S, Nath N, Chellappan SP. Arch Biochem Biophys; 2001 Apr 15; 388(2):243-52. PubMed ID: 11368161 [Abstract] [Full Text] [Related]
19. Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells. Gill RM, Slack R, Kiess M, Hamel PA. Exp Cell Res; 1998 Oct 10; 244(1):157-70. PubMed ID: 9770359 [Abstract] [Full Text] [Related]
20. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter. Rotheneder H, Geymayer S, Haidweger E. J Mol Biol; 1999 Nov 12; 293(5):1005-15. PubMed ID: 10547281 [Abstract] [Full Text] [Related] Page: [Next] [New Search]